Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01347723 · ClinicalTrials.gov registry record
Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 194
- Enrollment target
NCT01347723: Completed study, sponsored by Mayo Clinic.
NCT01347723 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 194 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01347723 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 194 participants
- Enrollment target
Study Summary
This pilot clinical trial studies scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy. Scrambler therapy may help relieve pain from peripheral neuropathy caused by chemotherapy
Interventions
- OTHER questionnaire administration
- PROCEDURE management of therapy complications
- OTHER scrambler therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01347723
The ClinicalTrials.gov registry entry for NCT01347723 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01347723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01347723 about?
NCT01347723 is a clinical study titled "Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy". This pilot clinical trial studies scrambler therapy in treating pain and peripheral neuropathy in patients previously treated with chemotherapy. Scrambler therapy may help relieve pain from peripheral neuropathy caused by chemotherapy
What is the current status of trial NCT01347723?
This trial is currently completed. The enrollment target is 194 participants. The study started on 2011-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01347723?
The interventions under investigation include: questionnaire administration (OTHER), management of therapy complications (PROCEDURE), scrambler therapy (OTHER).
Who is sponsoring clinical trial NCT01347723?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.